NASDAQ:AXNX
Delisted

Axonics Modulation Technologies Stock News

etoro logo Buy AXNX
*Your capital is at risk
$70.98
+0 (+0%)
At Close: Feb 13, 2025
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation ("SNM") devices for the treatment
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral
Presidente da Câmara criticou ato com pauta antidemocrática e inconstitucional em Brasília com participação de Bolsonaro. 'Lutamos contra o coronavírus e o vírus do extremismo', diz Maia.
Presidente cumprimentou apoiadores aglomerados em ato pró-intervenção militar e contra Congresso e STF. Ele disse que 'chegamos no limite' e que 'não vai admitir mais interferência'.
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
BidaskClub lowered shares of Axonics Modulation Technologies (NASDAQ:AXNX) from a strong-buy rating to a buy rating in a research note released on Friday, BidAskClub reports. Several other equities re
Axonics Modulation Technologies Inc (NASDAQ:AXNX) was the target of unusually large options trading activity on Thursday. Stock traders purchased 628 call options on the stock. This is an increase of
Evento promovido por centrais sindicais para celebrar o Dia do Trabalhador durou mais de seis horas e também contou com apresentações de artistas, como Roger Waters e Zélia Duncan.
Presidente classificou de 'política' decisão liminar (provisória) do ministro, que apontou 'desvio de finalidade' e suspendeu nomeação do delegado Alexandre Ramagem para a direção da PF.
Presidente editou medida em março, e Rede Sustentabilidade pediu ao STF que suspendesse trechos que restringiam a LAI. Relator atendeu a pedido, e o plenário confirmou a decisão.
Axonics Modulation Technologies Inc :
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation ("SNM") devices for the treatment
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE